Billy McKinney

Billy McKinney

Ask VT AI

View News Summary

Ongoing tariff disputes create economic strain for the US, Canada, and Taiwan, with policymakers grappling with the fallout.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
StockStory warns investors to prioritize firms with sustainable growth, healthy cash flow, and durable returns, rather than relying solely on current profitability or cash generation.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Ongoing tariff disputes create economic strain for the US, Canada, and Taiwan, with policymakers grappling with the fallout.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
StockStory warns investors to prioritize firms with sustainable growth, healthy cash flow, and durable returns, rather than relying solely on current profitability or cash generation.

20 days

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Billy McKinney